Uganda is set to introduce a new long-acting HIV prevention drug, Lenacapavir, in 2026 under a United States-funded initiative, offering fresh hope in the fight against the epidemic.

Our projections show the substantial detrimental impacts that cuts to PEPFAR funding could have. Mitigation measures, including funding through alternative international donors or domestic government ...

Just like the non-celeb normies of the world, Gage has toxic traits, experience with STIs, and conflicting views on hookup culture. He's also had an awkward threesome and enjoys a very specific kink ...

More than 50% of HIV diagnoses now occur in 48 counties in the United States. Cuyahoga County, home to Cleveland, is one of them.

Oct. 10, 2025, is officially the first-ever National PrEP Day, and MISTR and SISTR are going big. Their goal? Get 10,000 new people on PrEP in just 10 days. It’s ambitious, it’s impactful, and it just ...

In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by 2030. Now, however, Republicans are seeking deep cuts to HIV funding.

By the end of 2024, Bangladesh had registered 12,422 cumulative HIV cases, of which 2,281 had died. Health experts estimate that around 16,863 people are currently living with HIV in the country.

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

A new survey launched by Global Black Gay Men Connect is seeking responses from Black gay men and Black trans community members to learn more about the ...

Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, thanks to new partnerships with generic manufacturers.

Lenacapavir, approved by the FDA in June, requires only two shots a year. US insurers don't cover it, but access will soon increase abroad.